Melbourne Sexual Health Centre, Melbourne, VIC, Australia.
Royal Women's Hospital Melbourne, Melbourne, VIC, Australia.
Med J Aust. 2015 Apr 6;202(6):321-3. doi: 10.5694/mja14.00780.
To examine whether the rapid increase of gonorrhoea notifications in Victoria, Australia, identified by nucleic acid amplification test (NAAT) is supported by similar changes in diagnoses by culture, which has higher specificity, and to determine the proportion of tests positive among women tested.
DESIGN, SETTING AND PARTICIPANTS: Retrospective analysis of Medicare reporting of dual NAATs in Victoria, Victorian Department of Health gonorrhoea notifications, and gonorrhoea culture data at the Melbourne Sexual Health Centre (MSHC), among women, 2008 to 2013.
Gonorrhoea notifications and testing methods.
Gonorrhoea cases identified by NAAT increased from 98 to 343 cases over the study period. Notifications by culture alone decreased from 19 to five cases. The proportion of NAATs positive for gonorrhoea in Victoria was low (0.2%-0.3%) and did not change over time (P for trend, 0.66). Similarly, the proportion of women tested at the MSHC for gonorrhoea who tested positive (0.4%-0.6%) did not change over time (P for trend, 0.70). Of untreated women who had a positive NAAT result for gonorrhoea and were referred to the MSHC, 10/25 were confirmed by culture.
The positivity of gonorrhoea in women identified by culture remains stable over time. Using NAAT for gonorrhoea screening in low-prevalence populations will result in many false positives. Positive NAAT results among low-risk women should be regarded as doubtful, and confirmatory cultures should be performed.
通过核酸扩增试验(NAAT)发现澳大利亚维多利亚州淋病通知数量迅速增加,本研究旨在检查该结果是否与培养法诊断结果(具有更高特异性)的变化一致,并确定接受检测的女性中阳性检测的比例。
设计、地点和参与者:对维多利亚州医疗保险中双重 NAAT 报告、维多利亚州卫生署淋病通知以及墨尔本性健康中心(MSHC)淋病培养数据进行回顾性分析,检测对象为 2008 年至 2013 年期间的女性。
淋病通知和检测方法。
研究期间,通过 NAAT 确定的淋病病例从 98 例增加至 343 例。单独通过培养法确诊的淋病病例从 19 例降至 5 例。维多利亚州 NAAT 检测淋病的阳性率较低(0.2%-0.3%),且随时间变化无差异(趋势 P 值,0.66)。同样,在 MSHC 接受淋病检测的女性中,阳性检测结果的比例(0.4%-0.6%)随时间变化也无差异(趋势 P 值,0.70)。对于未经治疗且 NAAT 检测淋病阳性并被转诊至 MSHC 的女性,25 例中有 10 例经培养法确诊。
通过培养法确定的女性淋病阳性率随时间保持稳定。在低流行人群中使用 NAAT 进行淋病筛查将导致大量假阳性结果。低危女性的 NAAT 阳性结果应被视为可疑结果,应进行确认性培养。